These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6297384)

  • 21. Efficacies of piperacillin-tazobactam and cefepime in rats with experimental intra-abdominal abscesses due to an extended-spectrum beta-lactamase-producing strain of Klebsiella pneumoniae.
    Thauvin-Eliopoulos C; Tripodi MF; Moellering RC; Eliopoulos GM
    Antimicrob Agents Chemother; 1997 May; 41(5):1053-7. PubMed ID: 9145868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative activity of cefepime, ceftazidime and imipenem in a mouse infection caused by Klebsiella pneumoniae producing a broad spectrum beta-lactamase].
    Ronco E; Lawrence C; Nauciel C
    Pathol Biol (Paris); 1998 Oct; 46(8):651-5. PubMed ID: 9871937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria.
    Mohanty S; Gaind R; Ranjan R; Deb M
    J Infect Dev Ctries; 2009 Nov; 4(1):24-9. PubMed ID: 20130375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of experimental pneumonia due to penicillin-resistant Streptococcus pneumoniae in immunocompetent rats.
    Gavaldà J; Capdevila JA; Almirante B; Otero J; Ruiz I; Laguarda M; Allende H; Crespo E; Pigrau C; Pahissa A
    Antimicrob Agents Chemother; 1997 Apr; 41(4):795-801. PubMed ID: 9087492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of the dosage schedule on the efficacy of ceftazidime, gentamicin and ciprofloxacin in Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats.
    Roosendaal R; Bakker-Woudenberg IA; van den Berghe-van Raffe M; Vink-van den Berg JC; Michel BM
    Eur J Clin Microbiol Infect Dis; 1989 Oct; 8(10):878-87. PubMed ID: 2512132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of experimental pneumonia by infection with penicillin-insensitive Streptococcus pneumoniae in guinea pigs and their treatment with amoxicillin, cefotaxime, and meropenem.
    Ponte C; Parra A; Nieto E; Soriano F
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2698-702. PubMed ID: 9124825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial therapy of septicemia due to Klebsiella pneumoniae in neutropenic rats.
    Winston DJ; Sidell J; Hairston J; Young LS
    J Infect Dis; 1979 Apr; 139(4):377-88. PubMed ID: 374646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime.
    Masuyoshi S; Hiraoka M; Inoue M; Tomatsu K; Hirano M; Mitsuhashi S
    Drugs Exp Clin Res; 1989; 15(1):1-10. PubMed ID: 2663406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Klebsiella pneumoniae meningitis in thalassemia major patients.
    Li CK; Shing MM; Chik KW; Lee V; Yuen PM
    Pediatr Hematol Oncol; 2001; 18(3):229-32. PubMed ID: 11293293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ceftazidime, ceftizoxime, cefotaxime and HR 221 in experimental chronic Escherichia coli pyelonephritis in rats.
    Marre R; Herhahn D; Schulz E; Freiesleben H; Sack K
    Infection; 1983; 11 Suppl 1():S54-6. PubMed ID: 6299968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
    Zarakolu P; Metan G; Hasçelik G; Akova M
    Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial polymers as therapeutics for treatment of multidrug-resistant Klebsiella pneumoniae lung infection.
    Lou W; Venkataraman S; Zhong G; Ding B; Tan JPK; Xu L; Fan W; Yang YY
    Acta Biomater; 2018 Sep; 78():78-88. PubMed ID: 30031912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cefotaxime in lower respiratory tract infections compared to cefazolin.
    Miki F; Shiota K
    J Antimicrob Chemother; 1980 Sep; 6 Suppl A():169-75. PubMed ID: 6252151
    [No Abstract]   [Full Text] [Related]  

  • 34. Bactericidal killing activities of cefepime, ceftazidime, cefotaxime, and ceftriaxone against Staphylococcus aureus and beta-lactamase-producing strains of Enterobacter aerogenes and Klebsiella pneumoniae in an in vitro infection model.
    Palmer SM; Kang SL; Cappelletty DM; Rybak MJ
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1764-71. PubMed ID: 7486916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of cefodizime on pulmonary inflammatory response to heat-killed Klebsiella pneumoniae in mice.
    Bergeron Y; Deslauriers AM; Ouellet N; Gauthier MC; Bergeron MG
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2291-4. PubMed ID: 10471581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The antibacterial activity of cefmetazole and other antibiotics to 463 isolates].
    Xu Y; Wang H; Chen M
    Zhonghua Nei Ke Za Zhi; 1997 Aug; 36(8):540-2. PubMed ID: 10436961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of multiresistant ceftazidime-susceptible Klebsiella pneumoniae isolates lacking TEM-26 after class restriction of cephalosporins.
    Urban C; Mariano N; Rahman N; Queenan AM; Montenegro D; Bush K; Rahal JJ
    Microb Drug Resist; 2000; 6(4):297-303. PubMed ID: 11272258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic studies of cefepime (BMY 28142) in murine meningitis and pharmacokinetics in neonatal rats.
    Tsai YH; Bies M; Leitner F; Kessler RE
    Antimicrob Agents Chemother; 1990 May; 34(5):733-8. PubMed ID: 2360814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins.
    Meyer KS; Urban C; Eagan JA; Berger BJ; Rahal JJ
    Ann Intern Med; 1993 Sep; 119(5):353-8. PubMed ID: 8135915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of MicroScan WalkAway and Vitek 2 for determination of the susceptibility of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates to cefepime, cefotaxime and ceftazidime.
    Jang W; Park YJ; Park KG; Yu J
    J Antimicrob Chemother; 2013 Oct; 68(10):2282-5. PubMed ID: 23671215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.